# 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

> **NCT03300609** · PHASE3 · TERMINATED · sponsor: **University of Southern California** · enrollment: 4 (actual)

## Conditions studied

- Colorectal Adenocarcinoma
- RAS Wild Type
- Stage III Colorectal Cancer AJCC v7
- Stage IIIA Colorectal Cancer AJCC v7
- Stage IIIB Colorectal Cancer AJCC v7
- Stage IIIC Colorectal Cancer AJCC v7
- Stage IV Colorectal Cancer AJCC v7
- Stage IVA Colorectal Cancer AJCC v7
- Stage IVB Colorectal Cancer AJCC v7

## Interventions

- **BIOLOGICAL:** Panitumumab
- **DRUG:** Oxaliplatin
- **DRUG:** Leucovorin Calcium
- **DRUG:** Fluorouracil
- **DRUG:** Capecitabine
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT03300609
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-27
- **Primary completion:** 2019-10-03
- **Final completion:** 2019-10-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Insufficient Accrual
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03300609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03300609, "5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03300609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*